English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Upper airway muscle stimulation can improve pharyngeal muscle tone and thus could be considered for treatment of obstructive sleep apnoea (OSA). We present a novel device SnooZeal® that uses daytime awake neuromuscular electrical stimulation (NEMS) as an application to induce oropharyngeal muscular training. This study demonstrates objective and subjective usefulness of SnooZeal® in improving Mild OSA. Methods Prospective cohort study of 40 patients with Mild OSA (Apnoea-Hypopnea Index of 5-15/hour) was conducted. Objective respiratory parameters were recorded with two consecutive WatchPat sleep studies before and after treatment with the SnooZeal® device. The device was used by the patients for 20 minutes every day for 6 weeks. Furthermore, visual analogue scale for the snoring was completed by the partner as was the Epworth Sleepiness Score (ESS) as secondary outcome measures over the duration of the study. Results A statistically significant improvement was demonstrated in this cohort with mean AHI (Apnoea-Hypopnea Index) dropping from 9.91/hour prior to treatment to 5.2/hour following the treatment. The Oxygen desaturation index also reduced from a mean of 7.9 to 4.7 and similarly, there was also a statistically significant drop in the ESS from 8.86 to 5.43.Objective reduction in snoring was also demonstrated on the sleep studies in 95% of patients with an average reduction of 48% which was reflected subjectively by 40%reduction as recorded on visual analogue scale by partners. Conclusion SnooZeal® device study in this cohort of mild OSA patients demonstrates encouraging results. It offers the advantage of not requiring a device in situ whilst asleep which many patients find annoying and intolerable and thus a useful treatment option in patients with snoring and mild OSA. The device improves the muscle tone of the tongue and hence the upper airway dimensions during sleep. Support  

0643 Daytime Intra-Oral Neuromuscular Stimulation Therapy on Patients With Mild Obstructive Sleep Apnoea